Evelyn Partners Investment Management Services Ltd Buys 1,601 Shares of Intuitive Surgical, Inc. $ISRG

Evelyn Partners Investment Management Services Ltd lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.2% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,884 shares of the medical equipment provider’s stock after buying an additional 1,601 shares during the quarter. Intuitive Surgical makes up about 1.3% of Evelyn Partners Investment Management Services Ltd’s investment portfolio, making the stock its 21st largest position. Evelyn Partners Investment Management Services Ltd’s holdings in Intuitive Surgical were worth $11,010,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of ISRG. Brighton Jones LLC increased its holdings in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Sivia Capital Partners LLC grew its holdings in Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares in the last quarter. Schnieders Capital Management LLC. grew its holdings in Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after buying an additional 268 shares in the last quarter. Osterweis Capital Management Inc. bought a new stake in Intuitive Surgical in the 2nd quarter worth approximately $200,000. Finally, Main Street Financial Solutions LLC increased its stake in Intuitive Surgical by 92.4% in the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after acquiring an additional 1,407 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Amy L. Ladd sold 119 shares of the stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the sale, the director directly owned 120 shares in the company, valued at approximately $55,620. This represents a 49.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 6,669 shares of company stock valued at $2,822,405. 0.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Stifel Nicolaus lowered their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Sanford C. Bernstein reduced their price target on shares of Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Citigroup lowered their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Finally, Piper Sandler set a $357.44 price objective on shares of Intuitive Surgical in a research report on Monday. Twenty-one investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $519.13.

Intuitive Surgical Trading Up 5.7%

Shares of ISRG opened at $356.83 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The company has a market cap of $126.06 billion, a P/E ratio of 40.87, a P/E/G ratio of 2.44 and a beta of 1.46. The company’s fifty day simple moving average is $405.22 and its 200-day simple moving average is $457.57.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.81 EPS. Analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.